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Postural Hyperventilation as a Cause of Postural Tachycardia
Syndrome: Increased Systemic Vascular Resistance and Decreased
Cardiac Output When Upright in All Postural Tachycardia Syndrome
Variants
Julian M. Stewart, MD, PhD; Paul Pianosi, MD; Mohamed A. Shaban, MBBCH; Courtney Terilli, RN; Maria Svistunova, MS;
Paul Visintainer, PhD; Marvin S. Medow, PhD
Background-—Postural tachycardia syndrome (POTS) is a heterogeneous condition. We stratiﬁed patients previously evaluated for
POTS on the basis of supine resting cardiac output (CO) or with the complaint of platypnea or “shortness of breath” during
orthostasis. We hypothesize that postural hyperventilation is one cause of POTS and that hyperventilation-associated POTS occurs
when initial reduction in CO is sufﬁciently large. We also propose that circulatory abnormalities normalize with restoration of CO2.
Methods and Results-—Fifty-eight enrollees with POTS were compared with 16 healthy volunteer controls. Low CO in POTS was
deﬁned by a resting supine CO <4 L/min. Patients with shortness of breath had hyperventilation with end tidal CO2 <30 Torr
during head-up tilt table testing. There were no differences in height or weight between control patients and patients with POTS or
differences between the POTS groups. Beat-to-beat blood pressure was measured by photoplethysmography, and CO was
measured by ModelFlow. Systemic vascular resistance was deﬁned as mean arterial blood pressure/CO. End tidal CO2 and
cerebral blood ﬂow velocity of the middle cerebral artery were only reduced during head-up tilt in the hyperventilation group,
whereas blood pressure was increased compared with control. We corrected the reduced end tidal CO2 in hyperventilation by
addition of exogenous CO2 into a rebreathing apparatus. With added CO2, heart rate, blood pressure, CO, and systemic vascular
resistance in hyperventilation became similar to control.
Conclusions-—We conclude that all POTS is related to decreased CO, decreased central blood volume, and increased systemic
vascular resistance and that a variant of POTS is consequent to postural hyperventilation. ( J Am Heart Assoc. 2018;7:e008854.
DOI: 10.1161/JAHA.118.008854.)
Key Words: blood ﬂow regulation • blood volume • hyperventilation • orthostatic intolerance • tachycardia • vasoconstriction
• ventilation
S tanding upright (orthostasis) translocates central bloodvolume (CBV) to the dependent body and can precipitate
orthostatic intolerance (OI). Symptoms of OI generally begin
within 5 minutes of orthostatic stress. OI is deﬁned by signs,
such as changes in heart rate (HR), blood pressure (BP), or
respiration; and symptoms, such as lightheadedness, head-
ache, nausea, fatigue, cognitive deﬁcits, and exercise intoler-
ance starting while upright and relieved by recumbency.1,2
Postural tachycardia syndrome (POTS), a common form of
chronic OI, is associated with excess upright tachycardia in
the absence of hypotension.3–5
Dyspnea, hyperventilation, and hypocapnia have been
reported in association with POTS and also in other forms of
OI, including neurogenic orthostatic hypotension and vaso-
vagal syncope.6–8 Circulatory collapse9 and milder perturba-
tions, such as induction of hypotension in healthy volunteers,
result in hyperventilation and hypocapnia.10,11 Hypotension
and reduced cardiac output (CO) precedes hyperventilation in
these OI variants and may act by causing ischemia of the
carotid body (“stagnant hypoxia”),12 in part related to
sympathetic vasoconstriction of the artery to the carotid
body.13
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Systemic hypotension, however, does not cause hyper-
ventilation in POTS because, by deﬁnition, hypotension is
absent in POTS.3–5 Nevertheless, intermittent hyperventila-
tion, presenting as postural hypocapnic hyperpnea, has been
reported.14–17 We observed hypocapnic hyperpnea in POTS in
response to a rapid initial orthostatic decrease in CO and
CBV.15 In contrast, hyperventilation has not been observed
during past experiments using graded incremental upright
tilt.18
Hyperventilation produces sinus tachycardia, whereas
resultant hypocapnia reduces cerebral blood ﬂow, and results
in symptoms and maladaptive effects, including impaired
neuronal activation.19 Hypocapnia can be eliminated or
diminished by artiﬁcial CO2 rebreathing or by adding CO2 to
inhaled gas sufﬁcient to produce eucapnia while maintaining
oxygen concentration constant.20
We hypothesize that postural hyperventilation is a cause
of POTS with normal CO supine, but decreased CO,
decreased CBV, and increased systemic vascular resistance
(SVR) common to all with POTS when upright. We further
propose that hyperventilation-associated POTS occurs when
initial reduction in CO is sufﬁciently large and that
circulatory abnormalities normalize with restoration of
CO2.
21,22
Methods
The data, study materials, and analytic methods beyond those
described in this article will be made available to other
researchers by the authors for purposes of reproducing the
results or replicating the procedure on reasonable request
and Institutional Review Board approval.
Subjects
We enrolled 58 consecutive subjects previously diagnosed
with POTS. Subjects with POTS were 13 to 26 years old
(mean age, 18.11.2 years; 54 women and 4 men), with
POTS deﬁned by standard criteria.3,23 All patients had
symptoms for ≥6 months of chronic day-to-day symptoms
of OI and symptom relief when once again supine. POTS
was identiﬁed during tilt table testing by signs and
symptoms of OI and an excessive increase in HR without
hypotension within 10 minutes of head-up tilt.4,24,25 Exces-
sive tachycardia is deﬁned in adolescents by an increase in
HR of at least 40 beats per minute or an HR >120 beats
per minute in the absence of postural hypotension and
deﬁned in patients >19 years by an HR increase of
30 beats per minute, during a 10-minute upright tilt table
test.3,6 Other medical problems that could explain these
signs or symptoms had been ruled out. We excluded
potential enrollees with a history of respiratory disease,
sleep apnea, or obesity. Patients with diagnosed panic
disorder were also excluded.
Sixteen healthy volunteers were enrolled as control
subjects, aged 14 to 24 years old (mean age, 19.42.4
years; 15 women and 1 man). Healthy control subjects
recruited from the local community were nonsmokers, with no
previously known medical conditions, free of systemic illness,
taking no medications, with a normal physical examination
and ECG. Healthy control subjects were included only if free
of OI of any type, including orthostatic hypotension, POTS, or
syncope.
We stratiﬁed subjects with POTS on the basis of supine
resting CO measured by inert gas rebreathing technique
(Innocor-Innovision, Denmark). The lowest supine resting CO
in control subjects was 4.2 L/min; therefore, low CO in POTS
was deﬁned a priori by a supine resting CO <4.0 L/min. In
addition, we identiﬁed patients with POTS who complained of
shortness of breath while upright. All of these patients had
normal pulmonary function test results and no discernible
cardiopulmonary or systemic illness. We regarded these
dyspneic patients as a distinct subgroup of patients with POTS.
Patients were required to refrain from use of all
medications for at least 2 weeks before study, with the
exception of contraceptive or thyroid medications. Potential
enrollees who could not wean off vasoactive or neuroactive
medications were excluded. Enrollees were required to stop
ingestion of xanthine-, caffeine-, or alcohol-containing
substances 72 hours before study. A light breakfast was
permitted on testing day if eaten ≥2 hours before testing.
The Institutional Review Board of New York Medical
College reviewed and approved this protocol. Each subject
received a detailed description of all protocols and was given
Clinical Perspective
What Is New?
• We describe a subset of patients with postural tachycardia
syndrome who, as a consequence of an imposed orthostatic
challenge, exhibit postural hyperventilation in the form of
hypocapnic hyperpnea, causing reduced cerebral blood ﬂow
velocity, consequent lightheadedness, and increased blood
pressure; the hemodynamic deﬁcits of this postural tachy-
cardia syndrome group can be corrected by supplemental
CO2.
What Are the Clinical Implications?
• Hypocapnic hyperventilation is known to produce tachycar-
dia and symptoms often associated with orthostatic intol-
erance; therefore, postural hyperventilation causes a form of
postural tachycardia syndrome.
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an opportunity to have his or her questions answered. Signed
informed consent was obtained from all participants or their
parents.
Instrumentation
All subjects were instrumented in a similar manner by the same
operator. Height and weight were measured, and body mass
index was calculated. During instrumentation, all subjects lay
supine on an electronic motorized tilt table (Colin Medical
Instruments Corp, San Antonio, TX) with a footboard. An
electrocardiograph measured HR from the beat-to-beat cardiac
electrical interval. Beat-to-beat BP was monitored using ﬁnger
arterial plethysmography (Finometer; FMS, Amsterdam, the
Netherlands) on the right middle or index ﬁnger and corrected
for tilt angle, using ModelFlow software.26 Finometer data were
calibrated to brachial artery pressure and intermittently
checked against oscillometric BP measurements.
The Finometer uses the ModelFlow algorithm to estimate
beat-to-beat CO by pulse-wave analysis. Before experiments
began, ModelFlow CO was calibrated against an Innocor inert
gas rebreathing CO measurement (Innovision, Denmark) while
supine. We computed SVR by dividing the time average arterial
pressure (AP; mean AP [MAP]) by the ModelFlow CO averaged
over each cardiac cycle. The ﬁrst value of SVR was calculated
by measuring a manual BP, calculating the estimated MAP
from the formula MAP=(systolic BP+2 diastolic BP)/3, and
dividing that result by the Innocor-measured CO. Thereafter,
continuous SVR was calculated from ModelFlow data.
We placed paired electrodes using anatomic landmarks to
estimate thoracic, splanchnic, pelvic, and calf segmental blood
volumes, by high-frequency impedance plethysmography.27
Changes in electrical impedance were used to calculate
changes in segmental or regional blood volumes. We estimated
the change in blood volume in each segment after upright tilt
using the following formula:
Dsegmental blood volume (mL)=q(L2/R0R1)DR, where q is
electrical conductivity of blood estimated as 53.2exp(hema-
tocrit0.022).27 R0 is the initial impedance, R1 is its ﬁnal
value, and DR=R1R0 and L is the distance between the
electrode pairs.
Impedance plethysmography was measured using a tetrap-
olar, high-resolution, 4-channel digital impedance plethysmo-
graph, as previously described.14,27 These quantities were
obtained within 4 anatomic segments, deﬁned by electrode
placement on anatomic landmarks that delimit respective
regional circulations, designated the thoracic segment or CBV
(supraclavicular area to xyphoid process), the splanchnic
segment (xyphoid process to iliac crest), the pelvic segment,
including lower pelvis to the knee (iliac crest to knee), and the
leg or calf segment (upper calf just below the knee to the ankle).
Forearm and calf volume were also measured continuously
using mercury in silastic Whitney-type strain gauges (Hokan-
son, Bellevue, WA). This allowed us to detect and counsel
subjects against limb movements/muscle contractions that
could inﬂuence study results. This also allowed us to avoid
using data collected during times when limb movement was
recorded.
Respiratory plethysmography (Respitrace; NIMS Scientiﬁc,
Miami Beach, FL) normalized to pneumotachogram (Hans
Rudolph, Shawnee, KS) and nasal cannula capnography with a
pulse oximeter (Smith Medical PM, Waukesha, WI) measured
changes in respiration, end tidal CO2 (ETCO2), and oxygen
saturation. Transcranial Doppler (Neurovision; Multigon,
Yonkers, NY) measured cerebral blood ﬂow velocity (CBFv)
of the left middle cerebral artery using a 2-MHz probe ﬁxed to
the subject’s head by a custom-made headband. Signals were
acquired at 200 samples/second, multiplexed, and A/D
converted using custom software. These measurements are
routine during our tilt table studies.
Protocol
Subjects arrived at 9:30 AM. After instrumentation, subjects
remained awake and supine for 30 minutes to acclimate.
Baseline data comprised continuously measured HR, BP,
respiratory rate, tidal volume (TV), expiratory minute volume
(VE), ETCO2, CO, SVR, and CBFv. For purposes of comparison,
we used averaged data for the 10 minutes immediately
preceding tilt to determine baseline supine values. Mean
ETCO2 over the last 10 minutes of the rest period was deﬁned
as baseline eucapnia for each subject throughout the protocol.
After supine data collections were complete, all subjects
were tilted upright over 8 seconds to 70° for 10 minutes.
Continuously measured HR, BP, ETCO2, respiratory data, CO,
SVR, CBFv, and impedance data were recorded for off-line
analysis.
Spontaneous Hyperventilation (Hypocapnic
Hyperpnea) and Restoration of Eucapnia
Supine healthy volunteers had ETCO2 values that ranged
between 38 and 40 Torr. In all, ETCO2 decreasedmodestly with
upright tilt, but was never <33 Torr. We, therefore, deﬁned
hyperventilation by an upright ETCO2 consistently <30 Torr
that persisted during the tilt test. Patients who hyperventilated
received supplemental CO2 near the end of tilt using the
“dynamic end tidal forcing” technique,20 to return their ETCO2
to eucapnic levels. This allowed for the manipulation of the end-
tidal concentration of one gas while maintaining the end-tidal
concentration of the other gases constant. Eucapnia was
restored using 21% O2 balanced with N2 while maintaining CO2
near 40 Torr by adding CO2 to the breathing circuit as needed,
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as we have previously described.28 The patients maintained
spontaneous breathing frequency and TV throughout. A
rebreathing apparatus was used to control inspired gases.
Subjects were not aware of what, if any, intervention was being
performed, because they were not told when or if the gases that
they were breathing were altered. Subjects were not aware of
what their ETCO2 values were.
We used a 30-L breathing bag (Rusch, Research Triangle
Park, NC). The gas in the bag was constantly replenished from
cylinders of O2, CO2, and N2, and they were mixed to the
desired composition using a gas rotometer ﬂowmeter (model
FL-6GP; Omega Engineering, Stamford, CT). The breathing bag
was always fully inﬂated at the start of inspiration to ensure a
constant ﬂow. Two-stage gas ﬂow regulators (Western
Medica, Westlake, OH) connected to each of the 3 air
cylinders (O2, CO2, and N2) were used to achieve constant gas
ﬂow at the desired concentration of the air mixture balanced
with N2. The inhaled O2 concentration was measured
continuously and directly by an oxygen sensor (S-3A/I
Oxygen Analyzer with N-22M Sensor; AEI Technologies,
Naperville, IL) attached to gas conducting tubing, leading to
the patient. The oxygen sensor was calibrated using known
concentrations of O2 before each experiment. Normalized
respiratory impedance data were used to calculate respiratory
rate and estimate TV and VE. Data were detrended to remove
artifact, and TV was obtained as peak to trough volume per
breath. VE was determined by averaging TV over 1 minute and
multiplying by respiratory rate.
Data Analysis
All data were continuously sampled at 200 Hz, converted with
an analog-to-digital converter (DI-720 DataQ Ind, Milwaukee,
WI), connected to a personal computer, and analyzed ofﬂine.
Baseline data were recorded for 10 minutes before upright
tilt. The ﬁrst minute of tilt after a prolonged supine rest often
includes a period of hemodynamic instability known as “initial
orthostatic hypotension” (IOH),28 caused by the translocation
of blood from the upper body to the lower body while a lag in
compensatory adrenergic vasoconstriction allows a decrease
in CBV and BP and a concomitant increase in HR. For that
reason, the ﬁrst minute of tilt is often not used for analysis.
However, our prior data showed that this time period may be
critical to initiating hypocapnic hyperpnea.15 Therefore, we
retained all early physiological measurements following tilt,
and graphically displayed the nadir for BP, CO, and CBV and
the zenith for HR and SVR during this early tilt epoch, which is
designated as “initial.” Thereafter, upright measurements
were divided into 5 additional stages of “early” (2–4 minutes),
“middle” (4–6 minutes), “late” (6–8 minutes), “end”
(8–10 minutes), and “CO2.” Only hyperventilating patients
with POTS received CO2, and this additional epoch denoted
CO2 is included in the graphic results. Data were time
averaged during these time periods.
We deﬁned 3 groups of POTS on the basis of a priori
criteria: (1) decreased CO without hyperventilation (desig-
nated “POTS-↓CO”), deﬁned by CO <4 L/min; (2) normal CO
without hyperventilation (designated “POTS–normal CO”),
deﬁned by CO >4 L/min; and (3) hyperventilation (designated
“POTS-hyperventilation”). All POTS-hyperventilation had
supine CO >4 L/min at rest.
Data Presentation and Statistical Analysis
There were 3 POTS groups and 1 control group or 4 groups in
all.
Graphic data are predominantly shown as percentage of
baseline expressed as meanSEM. Thus, we are showing
percentage changes from baseline over time as a result of the
imposed orthostatic challenge, head-up tilt. Data were
obtained from original time series averaged over 15-second
intervals centered at the time markers. Data were collected
and analyzed by the same investigator throughout.
To assess the magnitude of difference in the heights and
weights of the 3 study groups, we computed x2. x2 Can be
interpreted as the proportion of the total variance that is
associated with the study groups. Values around 0.01 indicate
small differences among the study groups, whereas values
≥0.10 indicate large group differences.
We used repeated-measures ANOVA to compare study
groups on outcomes over time intervals. To address our
hypotheses, we were interested in how the study groups
differed in outcome measures over time during the tilt. As
such, we focused on the “group9time interaction” in the
repeated-measures ANOVA. We assumed a covariance struc-
ture of compound symmetry. Reported P values reﬂect the
interaction term using the Greenhouse-Geisser correction. To
control for multiple comparisons, pairwise comparisons
among groups following a signiﬁcant omnibus repeated-
measures ANOVA test were conducted using Scheffe’s test.
Statistical signiﬁcance was set at P≤0.05. Results were
calculated by using GraphPad Prism, version 4.0. All tabular
results are reported as meanSEM.
Results
There were 12 patients with POTS-↓CO, 32 patients with
POTS–normal CO, 14 patients with POTS- hyperventilation
and 16 healthy control subjects. For the patient groups,
height was 1624, 1684, 1663 cm, respectively, and
weight was 582, 602, and 614 kg, respectively. Height
was 1693 cm and weight was 672 kg for control
subjects. There were no differences in these parameters,
either within or between groups. In addition, the x2 values for
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height and weight represent small effect sizes, indicating little
difference in height and weight among the 3 study groups.
Supine Baseline Data
Baseline supine data for BP, HR, CO, SVR, CBFv, VE, and
ETCO2 are shown in the Table. There was no signiﬁcant
difference in MAP, ETCO2, or mean CBFv between subjects
with POTS and control subjects. Systolic BP was decreased
compared with control in POTS-↓CO, whereas diastolic BP was
increased in POTS–normal CO. There was a signiﬁcantly
higher supine HR and SVR, and lower supine CO and pulse
pressure, in POTS-↓CO compared with control subjects
(P<0.05). Oxygen saturation was always >96%.
Upright Tilt Data
Respiratory responses and CBFv
Respiratory data for all subjects are shown in Figure 1.
Oxygen saturation was always >96%. After tilt, increased TV
accounted for much of the VE increase (P<0.001) in POTS-
hyperventilation because there was a relatively small non-
signiﬁcant increase in respiratory rate. ETCO2 decreased
inversely to the VE increase for patients with POTS-
hyperventilation (P<0.0001), and CBFv decreased in parallel
(P<0.0001), as expected. There were no differences in the
parameters shown comparing the other POTS groups with
controls. Maximum ventilation in subjects with POTS was
achieved 2 to 4 minutes after head-up tilt and was maintained
throughout tilt. Administration of supplemental CO2, shown as
CO2, to achieve approximate eucapnia normalized CBFv and
signiﬁcantly decreased VE and TV (P<0.025), returning them
to near-control levels.
Hemodynamic responses to tilt
Figure 2 shows data averaged over all groups for HR, CO,
MAP, and SVR. After tilt, but before the delivery of CO2, HR
was signiﬁcantly increased for all POTS groups compared with
controls (P<0.0001). After tilt, CO was also decreased
compared with controls (P<0.001) and was signiﬁcantly lower
in POTS-↓CO compared with other patients with POTS
(P<0.025). Upright CO decreased in every patient with POTS.
SVR was similarly increased compared with control for all
POTS. MAP was only increased during tilt in POTS-hyperven-
tilation compared with control (P<0.025). SVR was increased
in every patient with POTS. After administration of supple-
mental CO2 to patients with POTS-hyperventilation, HR, CO,
MAP, and SVR were no longer different from control.
Regional blood volume responses to tilt
Figure 3 shows regional blood volume data, obtained by
impedance plethysmography, averaged over each POTS group
and control subjects. The percentage change of central blood
volume was reduced for all patients with POTS while upright
(P<0.001). There was an initial upswing in splanchnic blood
volume in POTS-hyperventilation and a less easily discerned
reciprocal change in CBV. Splanchnic blood volume exceeded
control in all POTS (P<0.01), whereas an increase in pelvic
Table. Supine Hemodynamic and Neurocardiopulmonary Data
Variable
Control Group
(n=16)
POTS-↓CO
Group (n=12)
POTS–Normal CO
Group (n=32)
POTS-Hyperventilation
Group (n=14)
Heart rate, bpm 643 835* 745 745
Systolic BP, mm Hg 1153 1032* 1143 1185
Diastolic BP, mm Hg 602 634 682* 622
MAP, mm Hg 794 774 814 813
Pulse pressure, mm Hg 543 424* 473 564
Respiratory rate, breaths/min 141 151 141 151
VE, L/min 6.80.7 7.40.7 6.70.7 7.90.9
Tidal volume, L 0.490.03 0.500.08 0.510.05 0.540.04
ETCO2, Torr 41.40.6 40.20.8 41.90.5 39.41.2
Cardiac output, L/min 5.70.4 3.40.2* 5.80.4 5.60.7
SVR, mm Hg/L per min 16.31.5 21.61.5* 15.11.0 15.61.4
Mean CBFv, cm/s 723 736 753 794
Data are given as meanSEM. The 3 groups were as follows: (1) POTS-↓CO, decreased CO without hyperventilation, deﬁned by CO <4 L/min; (2) POTS–normal CO, normal CO without
hyperventilation, deﬁned by CO >4 L/min; and (3) POTS-hyperventilation, hyperventilation. BP indicates blood pressure; bpm, beats per minute; CBFv, cerebral blood ﬂow velocity; CO,
cardiac output; ETCO2, end tidal CO2; MAP, mean arterial pressure; POTS, postural tachycardia syndrome; SVR, systemic vascular resistance; VE, minute ventilation.
*Different from control, P<0.05.
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volume in POTS did not reach signiﬁcance. Calf volume was
signiﬁcantly larger than control for POTS–normal CO and
POTS-hyperventilation, but not for POTS-↓CO (P<0.001). After
administration of supplemental CO2, CBV, splanchnic, pelvic,
and calf blood volumes were similar in subjects with POTS-
hyperventilation and control subjects.
Figure 4 shows a representative tracing from a patient
with POTS-hyperventilation. Beat-to-beat changes in AP, HR,
CO, VE, ETCO2, and CBFv are shown before and after
administration of supplemental CO2. This patient exhibited a
slight decrease in AP, a decrease in HR and VE, and an
increase in CO, ETCO2, and CBFv after CO2. Orthostatic
symptoms reported during these measurements improved
after CO2.
Discussion
Our major ﬁndings are as follows: CO is reduced and SVR is
increased without postural hypotension in POTS when upright,
compared with healthy volunteer control subjects. Reduced
CBV and increased SVR contribute to reduced CO in POTS. A
subset of patients with POTS also have reduced CO, increased
HR, and increased SVR when supine, corresponding to the
putative effects of increased central nervous system
Figure 1. Respiratory data and cerebral blood ﬂow velocity (CBFv) for all subjects. Respiratory rate (RR) contributes to the initial surge in
expiratory minute volume (VE); increased tidal volume (TV) accounts for the remainder of the VE increase in the postural tachycardia syndrome–
hyperventilation (POTS-HV) group. End tidal CO2 (ETCO2) decreased inversely to VE for patients with POTS-HV , whereas CBFv decreased in
parallel, as expected. CBFv decreased signiﬁcantly for POTS-HV. Administration of supplemental CO2 to achieve approximate eucapnia
normalized CBFv and improved VE and TV. POTS-↓cardiac output (CO) indicates decreased CO without hyperventilation, deﬁned by CO <4 L/
min; and POTS–normal (NL) CO, NL CO without hyperventilation, deﬁned by CO >4 L/min. **P<0.001, ***P<0.0001.
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sympathetic outﬂow characterizing the “hyperadrenergic
POTS” variant.29 Another subset of patients with POTS,
designated POTS-hyperventilation, have hyperventilation in
the form of hypocapnic hyperpnea, with reduced CBFv,
consequent lightheadedness, and increased BP. Patients with
POTS-hyperventilation comprise 25% of our enrolled
patients. Hyperventilation appears to be driven by early
enhanced decreases in CO, BP, and CBV. Postural hyperven-
tilation drives excessive upright tachycardia, causing POTS.
Hemodynamic deﬁcits of patients with POTS-hyperventilation
compared with control are corrected by supplemental CO2.
Arguably, this represents a separate syndrome in which the
primary ﬁnding is upright hypocapnic hyperpnea, which
secondarily results in excessive tachycardia.17
Figure 2. Data averaged over all groups for heart rate (HR),
cardiac output (CO), mean arterial pressure (MAP), and systemic
vascular resistance (SVR). Before the delivery of CO2, HR was
signiﬁcantly increased for all postural tachycardia syndrome
(POTS) groups compared with controls. CO was decreased
compared with controls and was signiﬁcantly lower in patients
with POTS-↓CO (decreased CO without hyperventilation) com-
pared with other patients with POTS. Upright CO decreased
signiﬁcantly and SVR increased signiﬁcantly in all POTS groups
compared with controls. MAP increased during tilt in the POTS-
hyperventilation (HV) group compared with control. After admin-
istration of supplemental CO2 to patients with POTS-HV, HR, CO,
MAP, and SVR were no longer different from control. NL indicates
normal; **P<0.001, ***P<0.0001, ‡P<0.025.
Figure 3. Regional blood volume data averaged over all groups
for subjects with postural tachycardia syndrome (POTS) and
control subjects. The percentage change of central blood volume
was reduced for all POTS groups before administering CO2.
Splanchnic blood volume in POTS-hyperventilation (HV) increased,
whereas central blood volume (CBV) reciprocally decreased,
during the initial period. Splanchnic blood volume in all POTS
groups exceeded control. Increased pelvic volume in POTS groups
did not reach signiﬁcance, although calf volume was signiﬁcantly
larger than control for POTS–normal CO (POTS-NL CO) and POTS-
HV, but not for POTS-↓CO (decreased CO without hyperventila-
tion). After administration of supplemental CO2, central and
regional blood volumes became similar in subjects with POTS-HV
and control subjects. *P<0.01, **P<0.001.
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POTS Is Characterized by Decreased CO and
Increased SVR When Upright
Decreased upright CO in POTS has been reported by our group
and by others,27,30,31 and is associatedwith increased SVR,27,31
consistent with sustained BP and marked reduction in upright
stroke volume.32 However, a subset of POTS may have
increased CO during exercise.33 In some respects, decreased
CO and increased SVR resemble observations made in decon-
ditioned individuals; indeed, exercise reconditioning can
improve cardiovascular ﬁndings in POTS.34 Some investigators,
however, have reported the simultaneous reduction of SVR and
CO.30 However, these changes would result in hypotension,
which, by deﬁnition, does not occur in POTS.
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Figure 4. Representative tracing from a patient with postural tachycardia syndrome (POTS)–hyperventilation. Beat-to-beat changes in arterial
pressure (AP), heart rate (HR), cardiac output (CO), expiratory minute volume (VE), end tidal carbon dioxide (ETCO2), and cerebral blood ﬂow
velocity (CBFv) are shown before and after administration of supplemental CO2. The ﬁgure suggests a small decrease in AP, a decrease in HR
and VE, and increases in CO, ETCO2, and CBFv after CO2 is administered. After CO2, the patient no longer fulﬁlls HR criteria for POTS.
Orthostatic symptoms improved, although VE remained somewhat elevated.
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Upright Central Blood Volume Is Reduced in POTS
Supine CBV is reduced in some patients with POTS.31,34–36
This is striking in those patients with evidence for increased
supine sympathoexcitation.37 Prior evidence and current data
support the excessive reduction in CBV in all patients with
POTS when upright,32 reducing cardiac preload and, thus,
CO. Central hypovolemia results primarily from sequestration
of blood within the splanchnic vasculature and, to a lesser
extent, within the lower extremities. Reduced CBV causes
reﬂex-mediated tachycardia,38 further potentiated by exces-
sive sympathetic outﬂow in those with hyperadrenergic
POTS.
Hyperventilation (Hypocapnic Hyperpnea)
Produces POTS, a Postural Hyperventilation
Syndrome
Hyperventilation syndrome may have fallen out of favor as a
stand-alone diagnosis. However, in the past, it had been
largely attributed to psychological factors when it occurred in
the absence of cardiac, respiratory, or well-deﬁned central
nervous system disorders.39 Hyperventilation accounted, in
large measure, for the so-called “effort syndrome” of World
War I,21 which was effectively treated by breathing CO2
mixtures or by CO2 rebreathing.
22
Postural hyperventilation has been reported once before
our work,40 and its physiological cause was minimized while
psychological causes remained paramount.41 The relationship
of hyperventilation to orthostasis has been revived by recent
reports from our laboratory14,15 and a report from the Mayo
autonomic group,17 contemporary with the deﬁnition of
POTS.3 More recently, “hyperventilation syndrome” (but not
“postural hyperventilation”) has been subsumed under the
aegis of “dysfunctional breathing” treated with variable
success by breathing retraining.42
Consequences of Hyperventilation (Hypocapnic
Hyperpnea)
The effects of uncontrolled spontaneous hyperventilation
are primarily the result of hypocapnia causing respiratory
alkalosis19; these effects substantially resolve when CO2 is
normalized.8,43 Because CO2 is lipid soluble, alkalotic changes
distribute across cell membranes and the blood-brain barrier.
Hypocapnia can cause tissue ischemia by decreasing the local
oxygen supply and increasing oxygen demand. There is a
leftward shift of the oxyhemoglobin dissociation curve, the
Bohr effect,44 and decreased release of oxygen at the tissue
level. Hypocapnia reduces cerebral blood ﬂow while increas-
ing cerebral oxygen demand, and cerebral ischemia with
reduced psychomotor function can result.45 Acute hypocapnia
also decreases myocardial oxygen delivery while increasing
cardiac oxygen demand46 via increases in myocardial con-
tractility and SVR. Gastrointestinal peristalsis is diminished,
which may contribute to the high incidence of gastrointestinal
symptoms reported by patients.47
Tachycardia in Hyperventilation
Three factors contribute to tachycardia during hyper-
ventilation48: the ﬁrst and least consequential depends on
lung inﬂation reﬂexes. Next in potency are the effects of
cerebral ischemia on the central medullary chemoreﬂexes and
on central inspiratory neurons.49 Third are direct actions of
hypocapnia on the sinoatrial node.48
Onset of Postural Hyperventilation Coincides
With Marked Decrease of CO, CBV, and CBF
During Initial Tilt: Importance of IOH and
Stagnant Hypoxia
Changing from supine to standing transfers >500 mL of CBV
caudally, transiently decreasing CBV and increasing blood
within the splanchnic vasculature and lower extremities.18,28,50
There is a period of IOH28 during which BP, CO, and CBF
transiently decrease because of the time lag in the onset of
sympathetic compensation. BP reaches its nadir 10 to
20 seconds after standing.51 Reﬂex tachycardia peaks a little
later, but BP and HR are usually restored within 30 to
60 seconds. Thereafter, upright HR slows but remains elevated
compared with supine; CBFv recovers to somewhat less than
supine,52 and BP is restored with a slightly higher MAP but
reduced pulse pressure. The ventilatory response to head-up
tilt is depicted in Figure 1.
IOH is larger in our patients with hyperventilation com-
pared with all other subjects, demonstrated by the exagger-
ated decrease in CBFv that coincides with a larger transient
decrease in CO and central blood volume compared with
control and other patients with POTS before BP restitution.
Reduced CBFv is immediately followed by hyperpnea and
hypocapnia. Hypocapnia perpetuates the reduced CBFv.43
Severely reduced CBF increases brain-wide vasoconstriction
and hypoxia-ischemia via the Bohr effect,44 resulting in
increased cerebral oxygen demand, neuronal excitability, and
continued sympathetic stimulation.19
Our study suggests that postural hyperventilation is not a
compensatory mechanism for POTS; rather, it causes POTS.
The respiratory pump (increased intra-abdominal and
decreased intrathoracic pressures) does not improve CO in
subjects with POTS14 because reduced blood volume and
extrathoracic pooling of blood severely hamper venous return.
On the contrary, if hyperpnea occurs at high operating lung
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volumes,53 thoracic blood volume may be even further
reduced.54
What Causes the Exaggerated Decrease in CBFv?
Rapidly decreased AP and CO during IOH drives decreased
CBF.55,56 Central blood volume and AP modulate cerebral
autoregulation.57 Central blood volume is also linked by
baroreﬂexes to cerebrovascular regulation via the extrinsic
(extracerebral) vascular innervation system. Excessive
baroreﬂex unloading causes parasympathetic withdrawal
and reduction of NO-dependent tonic dilation of the
extrinsic cerebral vasculature that counteracts cerebral
vasoconstriction. Our work supports the ability of this
extrinsic vasculature to respond well to NO in humans.58
Thus, the exaggerated initial decrease in CBFv may be
directly caused by the initial decrease in BP, CO, and CBV
of IOH and indirectly by reﬂex loss of NO-dependent
dilation of the extracerebral brain vasculature because of
parasympathetic withdrawal. CBF derives largely from
carotid artery blood ﬂow. A reduction in CBF implies a
reduction in carotid artery and carotid body blood ﬂows,
increasing the chemoreﬂex sensitivity to hypoxia.59 The
carotid body is primarily responsible for sensing “stagnant
ischemia” or “ischemic hypoxia” in conditions of reduced
CBV and CO.12 We have previously shown markedly
increased sympathetic nerve activity in these patients.15
We propose that chemoreﬂex-mediated sympathoexcitation
contributes importantly to vasoconstriction and increased
BP while further restricting CO in these patients.
Limitations
Transcranial Doppler only measures blood ﬂow through
speciﬁc cerebral blood vessels. The middle cerebral artery
was used because it is the main vessel that perfuses the area
of the brain activated during executive memory testing.
Perfusion during orthostatic stress may vary with brain
location, but such variations are often small.60 We did not
measure transcranial Doppler in both hemispheres because
previous work showed that middle cerebral artery CBFv was
not different between the hemispheres during orthostatic
stress.61
The Finometer yields relative measures of CO. Although we
standardized supine CO against inert gas rebreathing CO,
standardization was not performed during the tilt because the
technique requires deep breathing, which would alter hemo-
dynamics.
Impedance plethysmography cannot distinguish blood
pooling among the different thoracic organs (lung and heart)
or among the splanchnic organs (eg, liver versus mesenteric).
Although the technique measures fractional change in
regional blood volumes, these have been validated against
reference standards in prior studies.
This is a technique with superior temporal resolution but
imperfect accuracy, which, within limits, has been shown to
be sufﬁcient and satisfactory to compare directional changes
and relative magnitudes of changes in regional blood ﬂow and
blood volume among patients and volunteer control subjects
undergoing similar testing. We did not measure absolute total
blood volume or absolute central blood volume while supine.
However, we have shown in previous experiments that these
quantities are absolutely reduced for patients with POTS with
reduced resting CO.27
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